학술논문
Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 study
Document Type
Article
Author
Bataller, Alex; Montalban-Bravo, Guillermo; Bazinet, Alexandre; Alvarado, Yesid; Chien, Kelly; Venugopal, Sangeetha; Ishizawa, Jo; Hammond, Danielle; Swaminathan, Mahesh; Sasaki, Koji; Issa, Ghayas C; Short, Nicholas J; Masarova, Lucia; Daver, Naval G; Kadia, Tapan M; Colla, Simona; Qiao, Wei; Huang, Xuelin; Kanagal-Shamanna, Rashmi; Hendrickson, Stephany; Ravandi, Farhad; Jabbour, Elias; Kantarjian, Hagop; Garcia-Manero, Guillermo
Source
In The Lancet Haematology March 2024 11(3):e186-e195
Subject
Language
ISSN
2352-3026